CSH guidelines for the diagnosis and treatment of drug-induced liver injury.

YC, Yu; YM, Mao; CW, Chen; JJ, Chen; J, Chen; WM, Cong; Y, Ding; ZP, Duan; QC, Fu; XY, Guo; P, Hu; XQ, Hu; JD, Jia; RT, Lai; DL, Li; YX, Liu; LG, Lu; SW, Ma; X, Ma; YM, Nan; H, Ren; T, Shen; H, Wang; JY, Wang; TL, Wang; XJ, Wang; L, Wei; Q, Xie; W, Xie; CQ, Yang; DL, Yang; YY, Yu; MD, Zeng; L, Zhang; XY, Zhao; H, Zhuang

doi:10.1007/s12072-017-9793-2

Public

CSH guidelines for the diagnosis and treatment of drug-induced liver injury.

Shared by NobleBlocks on Apr 12, 2017 • 12:00 AM UTC

Authors:

Yu YC

Mao YM

Chen CW

Abstract

Drug-induced liver injury (DILI) is an important clinical problem, which has received more attention in recent decades. It can be induced by small chemical molecules, biological agents, traditional Chinese medicines (TCM), natural medicines (NM), health products (HP), and dietary supplements (DS). I...

Subject

Pathology

Diagnosis

Pathogenesis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!